Advisors who are monitoring hospitals' drug supply tactics are skeptical that the hospitals are seeking out these options with the intentions to drive down costs. (Photo: Shutterstock)
Pharmaceutical drug pricing continues to be a high cost driver for many health plans in America, and hospitals are attempting to curb that cost by manufacturing their own generic drugs, as well as seeking out more affordable bulk order supply chains.
According to a recent ABC News report, Civica Rx plans to start manufacturing 14 widely used hospital drugs that have long been in short supply. The company is not disclosing the drug names for competitive reasons, but they include a mix of generic pills, patches and injectables for treating infections, pain and heart conditions.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
